Similar articles

• PST 2238: A new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension.

  Ferrari P, Ferrandi M, Tripodi G, Torielli L, Padoani G, Minotti E, Melloni P, Bianchi G. Ferrari P, et al. J Pharmacol Exp Ther. 1999 Mar;288(3):1074-83. J Pharmacol Exp Ther. 1999. PMID: 10027844
• 17 beta-(3-furyl)-5 beta-androstane-3 beta, 14 beta, 17 alpha-triol (PST 2238). A very potent antihypertensive agent with a novel mechanism of action.

  Quadri L, Bianchi G, Cerri A, Fedrizzi G, Ferrari P, Gobbini M, Melloni P, Sputore S, Torri M. Quadri L, et al. J Med Chem. 1997 May 23;40(11):1561-4. doi: 10.1021/jm970162e. J Med Chem. 1997. PMID: 9171865 No abstract available.
• Endogenous cardiotonic steroids.

  Schoner W. Schoner W. Cell Mol Biol (Noisy-le-grand). 2001 Mar;47(2):273-80. Cell Mol Biol (Noisy-le-grand). 2001. PMID: 11355001 Review.
• Ouabain antagonists as antihypertensive agents.

  Ferrandi M, Barassi P, Molinari I, Torielli L, Tripodi G, Minotti E, Bianchi G, Ferrari P. Ferrandi M, et al. Curr Pharm Des. 2005;11(25):3301-5. doi: 10.2174/138161205774424735. Curr Pharm Des. 2005. PMID: 16250857 Review.
• Rostafuroxin: an ouabain-inhibitor counteracting specific forms of hypertension.

  Ferrari P. Ferrari P. Biochim Biophys Acta. 2010 Dec;1802(12):1254-8. doi: 10.1016/j.bbadis.2010.01.009. Epub 2010 Jan 18. Biochim Biophys Acta. 2010. PMID: 20083196 Review.